Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus

This study aims to determine the levels of Nε-(carboxymethyl)lysine (CML) in patients with Type 2 diabetic patients with and without ischemic heart disease (IHD) and to find for a possible association between circulating CML and a number of clinical parameters including lipids, hemoglobin A1c (HbA1c...

Full description

Bibliographic Details
Main Authors: Ahmed, Khaled A., Muniandy, Sekaran, Ismail, Ikram Shah
Format: Article
Language:English
Published: The Society for Free Radical Research Japan 2007
Subjects:
Online Access:http://eprints.um.edu.my/7223/1/Ahmed-2007-Role_of_N-epsilon-%28C.pdf
_version_ 1796945543759396864
author Ahmed, Khaled A.
Muniandy, Sekaran
Ismail, Ikram Shah
author_facet Ahmed, Khaled A.
Muniandy, Sekaran
Ismail, Ikram Shah
author_sort Ahmed, Khaled A.
collection UM
description This study aims to determine the levels of Nε-(carboxymethyl)lysine (CML) in patients with Type 2 diabetic patients with and without ischemic heart disease (IHD) and to find for a possible association between circulating CML and a number of clinical parameters including lipids, hemoglobin A1c (HbA1c) and malondialdehyde (MDA) in Type 2 diabetic IHD patients. Serum CML levels were measured by enzyme-linked immunosorbent assay using polyclonal anti-CML antibodies. Serum levels of CML and MDA were assessed in 60 IHD patients with Type 2 diabetes, 43 IHD patients without Type 2 diabetes, 64 Type 2 diabetics without IHD, and 80 sex- and age-matched healthy subjects. Correlations studies between CML levels and lipids, HbA1c, and lipid peroxidation were performed in Type 2 diabetes patients with and without IHD. A statistical significance was observed in the levels of serum glucose, lipids (triglyceride, total cholesterol, HDL-cholesterol), MDA, HbA1c, CML and LDL-cholesterol (p<0.05) between the groups of the study. CML levels were significantly increased in diabetic IHD patients compared with Type 2 diabetes patients but without IHD (537.1 ± 86.1 vs 449.7 ± 54.9, p<0.001). A positive correlation was observed between serum levels of CML and MDA, r = 0.338 (p = 0.008) in Type 2 diabetes patients with IHD. However, age, HbA1c and lipids had no significant influence on CML levels among diabetics (p>0.05). In conclusion, this study demonstrates the effect of both diabetes and oxidative stress on the higher levels of circulating CML. These results showed that increased serum levels of CML are associated with the development of IHD in Type 2 diabetes mellitus.
first_indexed 2024-03-06T05:18:17Z
format Article
id um.eprints-7223
institution Universiti Malaya
language English
last_indexed 2024-03-06T05:18:17Z
publishDate 2007
publisher The Society for Free Radical Research Japan
record_format dspace
spelling um.eprints-72232020-08-10T07:57:57Z http://eprints.um.edu.my/7223/ Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus Ahmed, Khaled A. Muniandy, Sekaran Ismail, Ikram Shah R Medicine This study aims to determine the levels of Nε-(carboxymethyl)lysine (CML) in patients with Type 2 diabetic patients with and without ischemic heart disease (IHD) and to find for a possible association between circulating CML and a number of clinical parameters including lipids, hemoglobin A1c (HbA1c) and malondialdehyde (MDA) in Type 2 diabetic IHD patients. Serum CML levels were measured by enzyme-linked immunosorbent assay using polyclonal anti-CML antibodies. Serum levels of CML and MDA were assessed in 60 IHD patients with Type 2 diabetes, 43 IHD patients without Type 2 diabetes, 64 Type 2 diabetics without IHD, and 80 sex- and age-matched healthy subjects. Correlations studies between CML levels and lipids, HbA1c, and lipid peroxidation were performed in Type 2 diabetes patients with and without IHD. A statistical significance was observed in the levels of serum glucose, lipids (triglyceride, total cholesterol, HDL-cholesterol), MDA, HbA1c, CML and LDL-cholesterol (p<0.05) between the groups of the study. CML levels were significantly increased in diabetic IHD patients compared with Type 2 diabetes patients but without IHD (537.1 ± 86.1 vs 449.7 ± 54.9, p<0.001). A positive correlation was observed between serum levels of CML and MDA, r = 0.338 (p = 0.008) in Type 2 diabetes patients with IHD. However, age, HbA1c and lipids had no significant influence on CML levels among diabetics (p>0.05). In conclusion, this study demonstrates the effect of both diabetes and oxidative stress on the higher levels of circulating CML. These results showed that increased serum levels of CML are associated with the development of IHD in Type 2 diabetes mellitus. The Society for Free Radical Research Japan 2007 Article PeerReviewed application/pdf en http://eprints.um.edu.my/7223/1/Ahmed-2007-Role_of_N-epsilon-%28C.pdf Ahmed, Khaled A. and Muniandy, Sekaran and Ismail, Ikram Shah (2007) Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus. Journal of Clinical Biochemistry and Nutrition, 41 (2). pp. 97-105. ISSN 0912-0009, DOI https://doi.org/10.3164/jcbn.2007014 <https://doi.org/10.3164/jcbn.2007014>. https://doi.org/10.3164/jcbn.2007014 doi:10.3164/jcbn.2007014
spellingShingle R Medicine
Ahmed, Khaled A.
Muniandy, Sekaran
Ismail, Ikram Shah
Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus
title Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus
title_full Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus
title_fullStr Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus
title_full_unstemmed Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus
title_short Role of Nε-(Carboxymethyl)Lysine in the Development of Ischemic Heart Disease in Type 2 Diabetes Mellitus
title_sort role of nε carboxymethyl lysine in the development of ischemic heart disease in type 2 diabetes mellitus
topic R Medicine
url http://eprints.um.edu.my/7223/1/Ahmed-2007-Role_of_N-epsilon-%28C.pdf
work_keys_str_mv AT ahmedkhaleda roleofnecarboxymethyllysineinthedevelopmentofischemicheartdiseaseintype2diabetesmellitus
AT muniandysekaran roleofnecarboxymethyllysineinthedevelopmentofischemicheartdiseaseintype2diabetesmellitus
AT ismailikramshah roleofnecarboxymethyllysineinthedevelopmentofischemicheartdiseaseintype2diabetesmellitus